MOROSINI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.917
AS - Asia 1.347
EU - Europa 1.191
SA - Sud America 238
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 4.756
Nazione #
US - Stati Uniti d'America 1.867
CN - Cina 618
SG - Singapore 288
IE - Irlanda 265
BR - Brasile 195
RU - Federazione Russa 152
FI - Finlandia 149
HK - Hong Kong 148
DE - Germania 146
VN - Vietnam 144
IT - Italia 115
UA - Ucraina 112
GB - Regno Unito 69
FR - Francia 64
SE - Svezia 45
ZA - Sudafrica 41
IN - India 37
CA - Canada 28
BD - Bangladesh 26
JP - Giappone 22
PL - Polonia 16
MX - Messico 15
AR - Argentina 13
IQ - Iraq 13
EC - Ecuador 8
NL - Olanda 8
TR - Turchia 8
BE - Belgio 7
CO - Colombia 7
ES - Italia 7
CZ - Repubblica Ceca 6
ID - Indonesia 6
LT - Lituania 6
PY - Paraguay 6
SA - Arabia Saudita 5
AL - Albania 4
CL - Cile 4
DZ - Algeria 4
MA - Marocco 4
UZ - Uzbekistan 4
VE - Venezuela 4
AT - Austria 3
CH - Svizzera 3
EU - Europa 3
PK - Pakistan 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DK - Danimarca 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
LV - Lettonia 2
MN - Mongolia 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
EG - Egitto 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.756
Città #
Dublin 265
Chandler 246
Ashburn 204
San Jose 194
Singapore 161
Beijing 151
Hong Kong 145
Dallas 136
Jacksonville 133
Nanjing 91
Boardman 72
Los Angeles 70
Helsinki 68
New York 65
Munich 46
Ho Chi Minh City 43
Princeton 40
Johannesburg 39
Pavia 39
Lauterbourg 37
Lawrence 37
Nanchang 37
Shenyang 35
Hanoi 33
Hebei 30
Shanghai 30
Wilmington 30
Changsha 29
Turku 29
Medford 28
Jiaxing 23
Moscow 23
Tokyo 21
São Paulo 20
Hangzhou 18
Buffalo 17
Milan 17
Ann Arbor 16
Tianjin 16
Council Bluffs 15
Orem 14
Seattle 14
Warsaw 14
Montreal 13
Redondo Beach 13
Verona 13
Washington 13
Brooklyn 12
Houston 12
London 12
Santa Clara 12
The Dalles 12
Poplar 10
Woodbridge 10
Columbus 9
Frankfurt am Main 9
Toronto 9
Belo Horizonte 8
Da Nang 8
Baghdad 7
Brussels 7
Fairfield 7
Haiphong 7
Manchester 7
Piscataway 7
Atlanta 6
Biên Hòa 6
Chennai 6
Denver 6
Nuremberg 6
Phoenix 6
Rio de Janeiro 6
San Francisco 6
Stockholm 6
Zhengzhou 6
Amsterdam 5
Mexico City 5
Mumbai 5
Ningbo 5
Ninh Bình 5
Vũng Tàu 5
Auburn Hills 4
Berlin 4
Falkenstein 4
Hải Dương 4
Norwalk 4
São José dos Campos 4
Taizhou 4
Tashkent 4
Ankara 3
Aracaju 3
Augusta 3
Bari 3
Boston 3
Brasília 3
Brescia 3
Caracas 3
Casablanca 3
Chicago 3
Curitiba 3
Totale 3.163
Nome #
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 175
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 167
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 158
Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection 153
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 150
Specific Anti-CMV Reactivity in BAL: A Useful Tool 142
Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis 139
Regulatory T cells in kidney transplant recipients. 138
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations 134
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 132
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 131
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 129
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 128
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 128
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors 127
Effects of continuous or pulsed exposure to rifabutin and sparfloxacin on the intracellular growth of Staphylococcus aureus and Mycobacterium tuberculosis 127
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 126
Experience with Cylex Immune Cell Function Assay in Clinical Immune Monitoring of Lung Transplant Recipients 125
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 125
Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors 124
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 121
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 119
Virulence of Mycobacterium tuberculosis affects inteleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes 118
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 116
A survey of antimicrobial drug resistance in respiratory tract pathogens, isolated in a northern Italian teaching hospital between 1990 and 1999 110
Possible Disease Markers in BAL Fluid of BOS Patients 109
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 107
Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study 107
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 105
Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles 104
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 98
Long-term off-line extracorporeal photochemotherapy in patients with chronic lung allograft rejection not responsive to conventional treatment: A 10-year single-centre analysis 98
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 97
Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients 89
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection 88
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome 84
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 83
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 83
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis 77
Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis 65
Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD 64
Totale 4.800
Categoria #
all - tutte 18.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022150 8 0 4 3 0 2 2 6 10 6 25 84
2022/2023704 70 65 2 56 60 73 0 36 309 6 18 9
2023/2024364 58 60 17 14 24 95 8 31 1 20 14 22
2024/2025870 23 46 21 30 23 88 66 65 201 19 102 186
2025/20261.799 151 86 201 213 256 99 339 85 159 109 56 45
Totale 4.800